EP1775293A4 - Antithrombozytenmittel und verfahren zu dessen herstellung - Google Patents

Antithrombozytenmittel und verfahren zu dessen herstellung

Info

Publication number
EP1775293A4
EP1775293A4 EP05768939A EP05768939A EP1775293A4 EP 1775293 A4 EP1775293 A4 EP 1775293A4 EP 05768939 A EP05768939 A EP 05768939A EP 05768939 A EP05768939 A EP 05768939A EP 1775293 A4 EP1775293 A4 EP 1775293A4
Authority
EP
European Patent Office
Prior art keywords
producing
same
antiplatelet agent
antiplatelet
agent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP05768939A
Other languages
English (en)
French (fr)
Other versions
EP1775293A1 (de
Inventor
Koji Sato
Syouko Yoshida
Tsutomu Yagi
Kenji Sakuratani
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Daiichi Pharmaceutical Co Ltd
Original Assignee
Daiichi Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Daiichi Pharmaceutical Co Ltd filed Critical Daiichi Pharmaceutical Co Ltd
Publication of EP1775293A1 publication Critical patent/EP1775293A1/de
Publication of EP1775293A4 publication Critical patent/EP1775293A4/de
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50—Pyridazines; Hydrogenated pyridazines
    • A61K31/501—Pyridazines; Hydrogenated pyridazines not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Epidemiology (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
EP05768939A 2004-08-06 2005-08-05 Antithrombozytenmittel und verfahren zu dessen herstellung Withdrawn EP1775293A4 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2004230011 2004-08-06
PCT/JP2005/014405 WO2006013962A1 (ja) 2004-08-06 2005-08-05 抗血小板薬およびその製造方法

Publications (2)

Publication Number Publication Date
EP1775293A1 EP1775293A1 (de) 2007-04-18
EP1775293A4 true EP1775293A4 (de) 2009-09-16

Family

ID=35787240

Family Applications (1)

Application Number Title Priority Date Filing Date
EP05768939A Withdrawn EP1775293A4 (de) 2004-08-06 2005-08-05 Antithrombozytenmittel und verfahren zu dessen herstellung

Country Status (12)

Country Link
US (1) US20090137600A1 (de)
EP (1) EP1775293A4 (de)
JP (1) JPWO2006013962A1 (de)
KR (1) KR20070046099A (de)
CN (1) CN101072769A (de)
AU (1) AU2005268058A1 (de)
CA (1) CA2574626A1 (de)
IL (1) IL180988A0 (de)
MX (1) MX2007001566A (de)
NO (1) NO20070986L (de)
RU (1) RU2007108297A (de)
WO (1) WO2006013962A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101486714B (zh) * 2009-02-09 2013-03-20 沈阳药科大学 新噁嗪类化合物及其抗血小板聚集的用途
CN102924476A (zh) * 2009-02-09 2013-02-13 沈阳药科大学 新噁嗪类化合物及其用途
CN101486713B (zh) * 2009-02-09 2013-05-15 沈阳药科大学 呋喃并[2,3-h]色烯类化合物及其抗血小板聚集的用途
US8604199B2 (en) 2009-04-27 2013-12-10 Dow Agrosciences, Llc. Insecticidal pyridine compounds

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0987253A1 (de) * 1995-10-13 2000-03-22 Nissan Chemical Industries, Limited Pyrazolonderivate
WO2004050632A1 (en) * 2002-12-02 2004-06-17 Fujisawa Pharmaceutical Co., Ltd. Pyrazole derivatives useful as cox-i inhibitors

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PH27357A (en) * 1989-09-22 1993-06-21 Fujisawa Pharmaceutical Co Pyrazole derivatives and pharmaceutical compositions comprising the same
FR2692575B1 (fr) * 1992-06-23 1995-06-30 Sanofi Elf Nouveaux derives du pyrazole, procede pour leur preparation et compositions pharmaceutiques les contenant.
US7087630B2 (en) * 2002-06-27 2006-08-08 Nitromed, Inc. Cyclooxygenase 2 selective inhibitors, compositions and methods of use
PL377848A1 (pl) * 2003-02-07 2006-02-20 Daiichi Pharmaceutical Co., Ltd. Pochodne pirazoli
WO2004094407A1 (ja) * 2003-04-21 2004-11-04 Daiichi Pharmaceutical Co. Ltd. ５員複素環誘導体

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0987253A1 (de) * 1995-10-13 2000-03-22 Nissan Chemical Industries, Limited Pyrazolonderivate
WO2004050632A1 (en) * 2002-12-02 2004-06-17 Fujisawa Pharmaceutical Co., Ltd. Pyrazole derivatives useful as cox-i inhibitors

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of WO2006013962A1 *

Also Published As

Publication number Publication date
RU2007108297A (ru) 2008-09-20
US20090137600A1 (en) 2009-05-28
EP1775293A1 (de) 2007-04-18
WO2006013962A1 (ja) 2006-02-09
CN101072769A (zh) 2007-11-14
CA2574626A1 (en) 2006-02-09
KR20070046099A (ko) 2007-05-02
IL180988A0 (en) 2007-07-04
JPWO2006013962A1 (ja) 2008-05-01
NO20070986L (no) 2007-04-20
MX2007001566A (es) 2007-04-16
AU2005268058A1 (en) 2006-02-09

Similar Documents

Publication Publication Date Title
EP1783096A4 (de) Alpha-sialon-pulver und herstellungsverfahren dafür
EP1729881A4 (de) Wässrige flüssigkeit absorbierendes mittel und herstellungsverfahren dafür
EP1947121A4 (de) Wärmeexpandierbare mikrokugel und herstellungsverfahren dafür
EP1815820A4 (de) Zylindrisches glied und verfahren zu seiner herstellung
HK1101338A1 (en) Cleaning device and process for producing the same
EP1876398A4 (de) Verzweigte kühlmittelrelaiseinheit und verfahren zu ihrer herstellung
EP2070695A4 (de) Zierteil und herstellungsverfahren dafür
HK1110483A1 (en) Wig and process for producing the same
EP1935916A4 (de) Polyarylen und herstellungsverfahren dafür
EP1903984A4 (de) Stent und verfahren zu seiner herstellung
EP1714778A4 (de) Laminat und verfahren zu dessen herstellung
EP1832188A4 (de) Perücke und perückenherstellungsverfahren
HK1103947A1 (en) Liquid seasoning and process for producing the same
HK1100873A1 (en) Candy and process for producing the same
GB2421727B (en) Method for forming coating material and the material formed thereby
EP1895853A4 (de) Joghurtkäseprodukte und verfahren zu ihrer herstellung
EP2062601A4 (de) Schaum und verfahren zu seiner herstellung
EP1886981A4 (de) Wasserhalteform und herstellungsverfahren dafür
EP1878521A4 (de) Gleitteil und verfahren zu dessen herstellung
EP1727177A4 (de) Verfahren zur herstellung eines geschichteten glieds und geschichtetes glied
EP1757362A4 (de) Adsorbens und verfahren zu seiner herstellung
EP1608203A4 (de) Lautsprecher und verfahren zu seiner herstellung
EP1651018A4 (de) Substrat und prozess zu seiner herstellung
EP1935008A4 (de) Mikroelektronische anordnung und verfahren zu ihrer herstellung
EP1935022A4 (de) Mikroelektronische baugruppe und verfahren zu deren formung

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20070123

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI SK TR

DAX Request for extension of the european patent (deleted)
A4 Supplementary search report drawn up and despatched

Effective date: 20090818

17Q First examination report despatched

Effective date: 20091103

GRAP Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOSNIGR1

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20101228